Arrowhead Research reported $17.86M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Anika Therapeutics ANIK:US $ 17.99M 186K
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
Arrowhead Research ARWR:US $ 17.86M 1.67M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Cerulean Pharma CERU:US $ 1.82M 142.69K
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Merk MRK:US $ 2.25B 376M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Moderna Inc MRNA:US 121M 44M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Novartis NOVN:VX 3.71B 190M
Opko Health OPK:US $ 113.24M 950K
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Spectrum Pharmaceuticals SPPI:US $ 14.96M 642K
Tg Therapeutics TGTX:US $ 34.02M 7.26M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
Xencor XNCR:US $ 8.86M 637K
YTE INCY:US $ 168.86M 15.06M